L01FE02 PANITUMUMAB
TED · 519182-2026Award noticeawardedNo deadline given
Value
Estimated€415,069 · 10,042,172.64 CZK
Awarded€415,069 · 10,042,172.64 CZK
WinnerAmgen s.r.o.
Who already wins at this buyer
Firms with recorded awards from Fakultní nemocnice u sv. Anny v Brně in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 9 | €3,505,920 | 2026-07-24 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 7 | €1,314,810 | 2026-07-22 |
| PROMEDICA PRAHA GROUP, a.s. | 6 | €1,171,474 | 2026-07-27 |
| ViaPharma s.r.o. | 4 | €2,481,288 | 2026-07-16 |
| Bristol-Myers Squibb spol. s r.o. | 3 | €4,024,644 | 2026-07-14 |
Full buyer profile: what Fakultní nemocnice u sv. Anny v Brně buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Předmětem veřejné zakázky jsou průběžné dodávky léčiv s obsahem účinné látky L01FE02 PANITUMUMAB po dobu 4 let.